| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/2014 | US20140206631 Cardiac Glycoside Analogs in Combination with Emodin for Cancer Therapy |
| 07/24/2014 | US20140206625 Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions |
| 07/24/2014 | US20140206624 Treatment of leukemia |
| 07/24/2014 | US20140206618 Inhibitors of the Renal Outer Medullary Potassium Channel |
| 07/24/2014 | US20140206616 Sustained-Release Lipid Pre-Concentrate of Pharmacologically Active Substance And Pharmaceutical Composition Comprising The Same |
| 07/24/2014 | US20140206614 Compositions for Achieving a Therapeutic Effect in an Anatomical Structure |
| 07/24/2014 | US20140206612 Oral insulin therapies and protocol |
| 07/24/2014 | US20140206600 Charged lipoprotein complexes and their uses |
| 07/24/2014 | US20140206597 Opioid Prodrugs with Heterocyclic Linkers |
| 07/24/2014 | US20140205689 Method for Prolonging the Life of Animals |
| 07/24/2014 | US20140205688 Stimulating agent and stimulating composition |
| 07/24/2014 | US20140205682 Method based on bismuth ion for the treatment and prevention of a disease caused by a shiga toxin |
| 07/24/2014 | US20140205680 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
| 07/24/2014 | US20140205679 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy |
| 07/24/2014 | US20140205678 Tannin formulation for treating gastrointestinal spasms in a subject having colorectal cancer |
| 07/24/2014 | US20140205677 Methods of treating gastrointestinal spasms in a subject having colorectal cancer |
| 07/24/2014 | US20140205675 Horse feed dietary supplement composition derived from chia seed composition |
| 07/24/2014 | US20140205673 Product for parenteral nutrition of obese intensive-care patients |
| 07/24/2014 | US20140205672 Release control compositions |
| 07/24/2014 | US20140205670 Stable solid preparations |
| 07/24/2014 | US20140205669 dhS1P AND USE OF SAME AS AN ANTICANCER THERAPEUTIC AND IMMUNOMODULATOR |
| 07/24/2014 | US20140205663 Direct Compression Formulation and Process |
| 07/24/2014 | US20140205662 System and method for differentially timed local delivery of a combination pharmaceutical preparation for oral therapy |
| 07/24/2014 | US20140205661 Formulation for retinoid-containing soft gelatin capsules |
| 07/24/2014 | US20140205660 Abscisic acid against cancer |
| 07/24/2014 | US20140205659 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 07/24/2014 | US20140205657 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 07/24/2014 | US20140205655 OLIGOOXOPIPERAZINES FOR p53 REACTIVATION |
| 07/24/2014 | US20140205650 Coated suppositories |
| 07/24/2014 | US20140205649 Solvent cast film sustained release latanoprost implant |
| 07/24/2014 | US20140205648 Methods for the in situ treatment of bone cancer |
| 07/24/2014 | US20140205643 Use of alginate oligomers in combating biofilms |
| 07/24/2014 | US20140205639 Compositions suitable for the topical treatment of fungal infections of the skin and nails |
| 07/24/2014 | US20140205628 High molecular weight polysaccharide that binds and inhibits virus |
| 07/24/2014 | US20140205627 Composition and method to improve blood lipid profiles and reduce low density lipoprotein (ldl) per-oxidation in humans using algae based oils and astaxanthin |
| 07/24/2014 | US20140205618 Human fertility enhancement with cortisol reduction food |
| 07/24/2014 | US20140205616 Compositions and methods for the diagnosis and treatment of tumor |
| 07/24/2014 | US20140205605 Optimized antibodies that target hm1.24 |
| 07/24/2014 | US20140205596 Organic compounds |
| 07/24/2014 | US20140205595 Compounds and methods of prophylaxis and treatment regarding nicotinic receptor antagonists |
| 07/24/2014 | US20140205589 New stable anesthetic composition for reducing skin reactions |
| 07/24/2014 | US20140205584 Anti-tnf-alpha therapy for the mucopolysaccharidoses and other lysosomal disorders |
| 07/24/2014 | US20140205583 USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY |
| 07/24/2014 | US20140205569 Methods and compositions for preventing and treating osteoarthritis |
| 07/24/2014 | US20140205567 Macrocyclic Heterocyclic Compound for Inhibiting Hepatitis C Virus and Preparation and Use Thereof |
| 07/24/2014 | US20140205566 Cyclic nucleuoside derivatives and uses thereof |
| 07/24/2014 | US20140205564 Hepatitis C Virus Inhibitors |
| 07/24/2014 | US20140205559 Antifungal compositions for the treatment of skin and nails |
| 07/24/2014 | US20140205558 Sodium thiosulfate-containing pharmaceutical compositions |
| 07/24/2014 | US20140205542 Perfusive Organ Hemostasis |
| 07/24/2014 | DE102013200819A1 Wirkstoffkombinationen aus Dehydracetsäure und einem oder mehrere Polyolen Active compound combinations of dehydracetic and one or more polyols |
| 07/24/2014 | DE102013200802A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Dehydracetsäure und/oder ihren Derivaten Cosmetic or dermatological preparations containing dehydracetic and / or its derivatives |
| 07/24/2014 | DE102013001151A1 Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit Sprayable liquid formulation for nasal application in particular with increased local residence |
| 07/23/2014 | EP2757157A1 Modulation of mitophagy and use thereof |
| 07/23/2014 | EP2757152A1 Method for inhibiting cell growth, nucleic acid molecule having rna interference effect on nek10 variant gene, and anticancer agent |
| 07/23/2014 | EP2757105A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/23/2014 | EP2757103A1 Pyrrolidine-3-ylacetic acid derivative |
| 07/23/2014 | EP2757099A1 Apoptosis promoters |
| 07/23/2014 | EP2757096A1 Inhibitors of human immunodeficiency virus replication |
| 07/23/2014 | EP2757093A1 Guanidinobenzoic acid compound |
| 07/23/2014 | EP2756848A1 Method for preparing an adsorbed drone brood and the composition thereof |
| 07/23/2014 | EP2756845A1 Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA |
| 07/23/2014 | EP2756844A1 High drug load mesalazine sachet |
| 07/23/2014 | EP2756843A2 Positively charged water-soluble prodrugs of diclofenac with very fast skin penetration rate |
| 07/23/2014 | EP2756841A1 Pharmaceutical compositions comprising an acid salt |
| 07/23/2014 | EP2756840A1 Pharmaceutical composition for inhalation |
| 07/23/2014 | EP2756756A1 Novel formulations for treatment of migraine |
| 07/23/2014 | EP2756072A1 Method for enhancing crop yields by application of trehalose |
| 07/23/2014 | EP2755985A1 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 07/23/2014 | EP2755979A1 Phased dosing of clopidogrel |
| 07/23/2014 | EP2755977A1 6, 8- disubstituted purine compositions and their pharmaceutical and cosmetic use |
| 07/23/2014 | EP2755976A1 6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4]triazolo [4, 3 -a]pyradines as tyrosine kinase |
| 07/23/2014 | EP2755975A1 New enzyme inhibitor compounds |
| 07/23/2014 | EP2755974A1 New enzyme inhibitor compounds |
| 07/23/2014 | EP2755973A1 Substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them |
| 07/23/2014 | EP2755972A1 Indanyl-substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them |
| 07/23/2014 | EP2755971A1 Piperidine pyrazoles as fungicides |
| 07/23/2014 | EP2755970A1 Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
| 07/23/2014 | EP2755968A1 Novel polymorphic form of raltegravir potassium |
| 07/23/2014 | EP2755967A1 Heterocyclic compounds for the treatment of cystic fibrosis |
| 07/23/2014 | EP2755965A1 Novel imidazole amines as modulators of kinase activity |
| 07/23/2014 | EP2755964A1 Sulfonic acid salts of heterocyclylamide-substituted imidazoles |
| 07/23/2014 | EP2755963A1 New dihydroquinoline-2-one derivatives |
| 07/23/2014 | EP2755961A1 Solid forms of a transthyretin dissociation inhibitor |
| 07/23/2014 | EP2755960A1 Plant growth regulating compounds |
| 07/23/2014 | EP2755958A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 07/23/2014 | EP2755957A1 Synthesis of triazolopyrimidine compounds |
| 07/23/2014 | EP2755956A1 Disubstituted 5-fluoro-pyrimidines |
| 07/23/2014 | EP2755954A1 BI-AROMATIC AND TRI-AROMATIC COMPOUNDS AS NADPH OXIDASE 2 (Nox2) INHIBITORS |
| 07/23/2014 | EP2755953A1 3 -pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents |
| 07/23/2014 | EP2755952A1 5-cycloalkyl- or 5-heterocyclyl-nicotinamides |
| 07/23/2014 | EP2755950A1 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides |
| 07/23/2014 | EP2755948A1 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group |
| 07/23/2014 | EP2755942A2 Therapeutic compounds |
| 07/23/2014 | EP2755940A1 Anticancer active ingredient derived from guiera senegalensis |
| 07/23/2014 | EP2755756A1 Sorbent comprising on its surface an aliphatic unit having an anionic or deprotonizable group for the purification of organic molecules |
| 07/23/2014 | EP2755689A1 Methods for treating hcv |
| 07/23/2014 | EP2755667A2 Method for enhancing the growth and fullness of hair |
| 07/23/2014 | EP2755664A2 Retinal cyclodextrin acetals and hemiacetals for clarifying skin complexion |
| 07/23/2014 | EP2755663A1 Microrna inhibitors |